Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Epanutin

- PMLiVE

VIDEO: Eisai manufacturing plans shows UK is recovering from ‘shock’ of Pfizer/AZ cutbacks

David Willetts says life sciences industry has future in UK at opening of Fycompa manufacturing site

FDA sets new date for Eliquis review in atrial fibrillation

US regulator had asked for more data from Pfizer and BMS

Pfizer calls on pharmacists to promote medicine adherence

Unused medicines cost NHS England £300m per year

- PMLiVE

Pfizer’s RA drug tofacitinib tops methotrexate in phase III

Trial results back drug as major new treatment in rheumatoid arthritis

- PMLiVE

UK NHS reforms create £20bn opportunity for private sector

Report from Catalyst says NHS reforms pave way for healthcare companies

- PMLiVE

UK hospitals cannot cope with demand says RCP

Report claims acute care on “brink of collapse”

- PMLiVE

Finalists decided in UK cancer awards

QiC Excellence in Oncology aims to recognise good practice in cancer care throughout UK

Eisai launches epilepsy drug Fycompa in UK

CEO of Eisai EMEA Gary Hendler says UK “last free pricing market in Europe”

Pfizer forms branded generics sales alliance in China

Forms joint venture with local company Hisun

- PMLiVE

GSK persuades NICE to reconsider negative Benlysta decision

Decision on lupus drug referred to expert committee following appeal

- PMLiVE

NHS social network How Are You? launches UK’s first health app store

A partnership with Cambridge Healthcare, the network's store offers easy access to health apps

- PMLiVE

Scottish cabinet reshuffle sees Alex Neil made health secretary

Moves from infrastructure, investment and cities to take over from Nicola Sturgeon

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links